Merian Life Sciences ApS: Financial statements 2024
CVR: 40288589
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
Merian Life Sciences ApS (CVR 40288589) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 1,072,060 and a net result of DKK 835,491 compared with DKK 330,114 the year before. That is an increase of 128.5% compared with the year before. Equity in the 2024 report amounted to DKK 2,174,825. The solvency ratio was 82.7%.
- Gross Profit
- DKK 1,072,060
- Profit/Loss
- DKK 835,491
- Equity
- DKK 2,174,825
- Total Assets
- DKK 2,631,054
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 1.1M | 835K | 2.2M | 0 |
| 2023 | - | 469K | 330K | 1.5M | 0 |
| 2022 | - | 596K | 433K | 1.2M | 0 |
| 2021 | - | 394K | 290K | 930K | 0 |
| 2020 | - | 457K | 334K | 619K | 0 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
Merian Life Sciences ApS has published its annual report for 2023. Gross profit came to DKK 469,177, and the net result was DKK 330,114.
About Merian Life Sciences ApS
Merian Life Sciences ApS is a Danish company of the type Anpartsselskab based in Hellerup, founded in 2019. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Birgitte Menachem and Neil Goldsmith. The company is owned by Birgitte Menachem and Neil Goldsmith. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK 280,804 and a net result of DKK -36,911 compared with DKK 835,491 the year before. Equity in the 2025 report amounted to DKK 2,002,914.